Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,278 results for "Medical Malpractice Law & Strategy"...

Med Mal News
April 29, 2013
A look at recent news and litigation.
Drug & Device News
April 29, 2013
Recent news items of importance.
Failure-to-Detect Claims Against Dermopathologists
April 29, 2013
Last month, the author discussed a hypothetical medical malpractice case in which a dermopathologist midread a patient's pathology slide and then reported that no evidence of cancer was found. The discussion concludes herein.
Evidence-Based Medicine in the Courtroom
April 29, 2013
The time has come for medical malpractice expert causation testimony to fall in line with that employed in toxic tort cases, rightfully valuing proven scientific conclusions over experience-based expert opinion.
The Unforeseen Consequences of a Criminal Conviction
April 29, 2013
Even skilled criminal defense attorneys may unwittingly permit their clients to enter guilty pleas that could impair their client's medical license.
Verdicts
March 29, 2013
In-depth analysis of the latest litigation.
Drug & Device News
March 29, 2013
A roundup of key rulings.
Med Mal News
March 29, 2013
Analysis of the latest litigation.
Failure-to-Detect Claims Against Dermopathologists
March 29, 2013
In both PA and NJ, a claim for medical malpractice is not cognizable unless the "target" physician owes the plaintiff a duty of care. The duty of care owed by a dermopathologist arises by virtue of his or her willingness to undertake interpreting the cutaneous pathology slides.
Evidence-Based Medicine in Medical Malpractice Litigation
March 29, 2013
The evolution of evidence-based medicine should cast doubt upon advocacy that masquerades as science, and put courts in the position of deciding when science should prevail.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›
  • Meet the Lawyer Working on Inclusion Rider Language
    At the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers &amp; Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.
    Read More ›